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Introduction: 
 Microtubules (MTs) are dynamic cytoskeletal polymers composed of αβ-tubulin that 
define cell structure, establish platforms for the transportation of intracellular cargos, and form 
the mitotic spindle to facilitate chromosomal segregation. These hollow tube-like polymers are 
formed by the GTP hydrolysis-dependent head-to-tail polymerization of α- and β-tubulin 
heterodimers (1-3). The polarity of the heterodimer is reflected in the polymer; β-tubulin is 
exposed at the MT plus end where polymerization mainly occurs and α-tubulin is exposed at the 
minus end (1, 2) (Fig. 1). The dynamic 
properties of MTs are readily displayed 
at the interphase-mitosis transition. 
During interphase, MTs are much less 
dynamic and organize into a radial 
array; whereas, in mitosis, MTs are 
much more dynamic and assemble into 
the dense bipolar mitotic spindle (1, 2, 
5, 6). The remarkable diversity present 
within the dynamics of the interphase 
MT array versus the mitotic spindle 
proposes the existence of proteins that 
regulate MT dynamics (5, 6). One type of such proteins are MT-associated proteins (MAPs), 
which are crucial for the regulation of MT polymerization and depolymerization, as well as 
intracellular organization (7). Included among MAPs is the XMAP215 family, which was 












Figure 1. Polymerization (assembly) and depolymerization 
(disassembly) of MTs is driven by the binding, hydrolysis, and 
exchange of a guanine nucleotide on the β-tubulin monomer. The 
presence of the equilibrium between MT growing, shrinking and 
paused states confers microtubule dynamic instability. Crucial for 
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regulatory factors to catalyze rapid MT elongation (8). All of the proteins within the XMAP215 
family consist of a C-terminal domain that promotes XMAP215 localization via its interaction 
with other MAPs and an array of N-terminal TOG (tumor overexpressed gene) domains that 
interact with αβ-tubulin in order to facilitate MT growth, promote the formation of the mitotic 
spindle, and enhance MT dynamics (1, 2, 9-11). The number of TOG domains within the TOG 
domain array differs across XMAP215 family members (Fig. 2). Yeast homologs have only two 
TOG domains that 
comprise a dimeric 
structure, whereas higher 
eukaryotes are monomeric 
and contain a pentameric 
TOG domain array (4, 9, 
15). In juxtaposition to the 
TOG arrays observed in yeast and higher eukaryotes is the ZYG-9 TOG array, which is trimeric 
(12, 17). Connecting the TOG domains are linkers ranging from 60-100 amino acids. Although 
these linkers obtain no projected secondary structure, they do contain basic residues that are 
important for interacting with microtubules (16).  
Across all TOG arrays, TOG domains share conserved features. TOG domains are 
defined by six (A-F) HEAT (Huntingtin, elongation factor 2, protein phosphatase 2A, target of 
rapamycin 1) repeats (HRs) that align to form an oblong framework (17, 18) (Fig. 3A). The 
arrangement of intra-HEAT loops on one face of the TOG domain provides a conserved surface 
for proper tubulin binding (13) (Fig. 3B). How the XMAP215 TOG domain array utilizes 
conserved tubulin binding residues to bind and incorporate αβ-tubulin into MT plus ends is a 
	  
Figure 2. The XMAP215 family proteins share a conserved architecture, consisting of 
a C-Terminal domain or coiled-coil that associate with other MAPs and an N-terminal 
TOG array that interacts with αβ-tubulin. XMAP215 family TOG domain 
architectures solved to date are displayed in color.  
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long-standing question in the cytoskeletal field. Currently, there are two models to explain this 
phenomenon. The first is the 
wrap-around model, which 
suggests that XMAP215 
proteins utilize their TOG 
array(s) to surround a tubulin 
heterodimer and transport it to 
the MT plus end. On the other 
hand, the templating model assumes that each TOG domain within the array uses a similar 
mechanism to interact in a concerted manner with multiple tubulin heterodimers (8, 13, 18). To 
differentiate between these two proposed models, it is important to uncover the architecture and 
MT polymerization behaviors of each TOG domain within the array. Structure function 
investigations show that TOG domains 
differentially promote MT 
polymerization and spindle structure. 
Specifically, studies indicate that TOGs 
1-2 have a much greater affect on 
regulating MT dynamics than TOGs 3-5 
(9, 12).  
This differential ability to 
promote MT polymerization and spindle 
structure may be in part justified by 
structural deviations among TOG 
Figure 3. A. Stu2 TOG1 conserved tubulin-binding surface. B. Stu2 TOG1 
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Figure 4. TOG domain architectures currently solved, featuring ch-
TOG TOG4, Msps TOGs2-5, ZYG-9 TOG3, and Stu2 TOGs1-2. 
All TOG domains within the array consist of six (A-F) HRs.   
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domains. Presently, there have been eight TOG domain 
structures determined by X-ray crystallography that 
have provided substantial insight into the mechanism of 
XMAP215-mediated MT polymerization. These 
structures include Saccharomyces cerevisiae Stu2 
TOG1 and TOG2, Drosophilia melanogaster Mini 
spindles (Msps) TOG2, TOG3, TOG4, and TOG5, 
Caenorhabditis elegans ZYG-9 TOG3, and Homo 
sapiens ch-TOG TOG4 (12, 13, 17-20) (Fig. 4). Studies 
show that TOG1, TOG2, and TOG3 have conserved 
architectures, which contrast to the divergent structure 
of TOG4 (12, 20). In particular, TOGs 1-3 contain a 
similar tubulin-binding surface to facilitate 
complimentary interactions with tubulin 
heterodimers (Fig. 5). Conversely, studies report 
that TOG4 transiently binds tubulin, perhaps due to 
the differential positioning of the HR D-F triad 
(Fig. 6). The diverse tubulin-binding mechanism of 
TOG domains 1-3 versus TOG4 provides evidence 
for the contribution of a polarized arrangement of 
XMAP215 to promote MT dynamics (12, 18-20). It 
has further been discovered that the ultimate TOG 
domain in ZYG-9 (TOG3) and Msps (TOG5) have 





2.4 Å rmsd 
Figure 5. Msps TOG3 is most similar to Stu2 
TOG1, with an rmsd of 2.4 Å. The structural 
conservation between Msps TOG3 and Stu2 
TOG1 provides evidence that TOGs1-3 share a 






Figure 6. TOG4 is structurally divergent. Msps TOG4 
and Msps TOG3 aligned pairwise results in a 
differential arrangement of HRs D-F. Specifically, 
alignment yields an ~20 Å shift in HR F. These 
structural deviations suggest that TOG4 has an 
alternative tubulin-binding mechanism.  
Msps TOG3 Msps TOG4 
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similar domain architectures that deviate from other solved domain structures in the TOG array 
(19) (Fig. 6). Specifically, these domains have a characteristic seventh N-terminal HEAT repeat 
(HR) that binds orthogonal to HRs A-C. It is suspected that the N-terminal HR facilitates lateral 
tubulin interactions; however, its function is still at large (16). In addition, these domains have a 
conserved phenylalanine residue in intra-HR loop A, which contrasts with the tryptophan in the 
same position in TOG domains 1-4 (12). These conserved aromatic residues are exposed on the 
surface of the protein and have been shown to be of value in securing the interaction between the 
TOG domain and tubulin (15, 19).  
The inherent differences in TOG domain architectures and their affect on MT dynamics 
provoke two separate 
questions. The first is in 
regards to whether the 
TOG domains are 
similar or different in 
their functionality, and 
the second concerns the 
type of tubulin-binding 
mechanism utilized by 
the TOG domain array. I 
hypothesize that TOG 
domain architectures 
comprising XMAP215 
TOG domain arrays are 
Figure 7. A. Msps TOG5 displays noteworthy architectural characteristics, including an 
extra N-term HR and a conserved phenylalanine. B. Instead of a tryptophan, Msps TOG5 
has an equally aromatic residue, phenylalanine, which is positioned on the surface to 
promote tubulin binding. C-E. Residues R1157, E1151, and W1169 are hypothesized to be 
of significance in stabilizing the N-terminal HR. Point mutations were introduced in order 
to disrupt the extra HR to gain a better understanding of how this domain aids in overall 
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arranged in a specific orientation to distinguish between different tubulin structural states, which 
may play an important mechanistic role in XMAP215-mediated MT polymerization. To study 
this hypothesis, I am going to determine if TOG domain structures are conserved between 
XMAP215 family members, test the role of different TOG domain features in promoting domain 
stabilization, and understand how different TOG architectures affect MT polymerization. These 
studies will be achieved by (1) structurally characterizing TOG domains 3 and 5 from species 
across the XMAP215 family by X-ray crystallography, (2) completing the Msps TOG array by 
crystallizing Msps TOG1 (3) probing the role of TOG5’s extra N-terminal HR in promoting 
secondary structure and domain stability by creating mutant constructs and performing 
comparative circular dichroism studies, and (4) examining the effects of intra-HR loop A WE 
(TOG3) and FE (TOG5) mutations on the catalysis of MT polymerization by these TOG 
domains in a light scattering assay. Collectively, these experiments will provide further 
comprehension of the mechanism of XMAP215 proteins and will provide insight into how the 
architecture and structural elements of arrayed TOG domains dictate their functionality and 
differential contribution to MT dynamics.  
 
Methods:  
A. DNA Cloning 
 Unless otherwise stated, I performed the work presented in this paper. Preliminary 
alignments of Msps TOG1, ch-TOG TOG3 and TOG5 were used to determine the conserved 
residues between homologous proteins and respective domains. Using this information, primers 
were designed for amplification of Msps TOG1 (amino acids (aa) 6-234), ch-TOG TOG3 (aa 
593-828) and TOG5 (aa 1155-1425) with NdeI and BamHI restriction enzyme sites. Standard 
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PCR protocol was followed to amplify the desired DNA sequence of the Msps TOG1, ch-TOG 
TOG3 and TOG5 constructs. The Msps TOG1, ch-TOG TOG3 and TOG5 PCR products were 
digested with NdeI and BamHI restriction enzymes at 37 °C for 1 hour and 30 minutes. The 
purified Msps TOG1, ch-TOG TOG3 and TOG5 DNA products were then ligated into a precut 
pET28-p vector, a Kanamycin resistant bacterial expression vector that introduces an N-terminal 
His-tag, using T4 DNA ligase for an hour at 25 °C. For each construct, approximately 5 µL of 
the resulting DNA plasmid was transformed into 75 µL XL1B E. coli high copy cells and placed 
on ice for 20 minutes. The transformed bacteria was heat shocked at 37 °C for one minute and 
then placed on ice for an additional two minutes. Luria broth (LB) was added and the cells were 
incubated at 37 °C for approximately an hour. The bacteria was concentrated via centrifugation 
at 8,000 x g for four minutes and plated on kanamycin agar plates for selection. The transformed 
bacteria was allowed to incubate at 37 °C overnight.  
 In order to ensure that the DNA sequences of Msps TOG1, ch-TOG TOG3 and TOG5 
were successfully ligated into pET-28-p, colony PCR was performed using a T7 forward primer 
and BamHI reverse primer. The positive colonies were placed in a culture tube containing 5 mL 
LB and 5 µL Kanamycin to amplify the plasmid DNA. The plasmid DNA from the 5 mL 
growths was purified and confirmed by sequencing.  
 For the following mutagenic Drosophila melanogaster constructs, Msps TOG3 (aa 582-
825) W606E and Msps TOG5 (aa 1141-1411) R1157 E, E1161R, W1169E, and 
F1204E, the Quick Exchange PCR protocol was followed. These constructs were each 
digested with 1 µL DpnI for 1 hour and 30 minutes to cleave at the methylated sites of the 
template DNA. The constructs were then transformed into XL1B E. coli high copy cells. Viable 
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colonies were grown up in 5 mL culture tubes at 37 °C under kanamycin selection. The 
amplified plasmid DNA was purified and the sequences of the constructs were verified.   
B. Protein Expression and Purification  
 The desired constructs were transformed into BL21 DE3 E. coli high expression cells 
using the transformation protocol described above. Cultures containing 6 L LB were grown at  
37 °C under kanamycin selection. Once an optical density of 0.6 was reached, protein expression 
was induced with 0.1 mM ispropyl-1-thio-β-D-galactopyranoside and incubated at 18 °C 
overnight. The cells were pelleted via centrifugation, resuspended in buffer A (25 mM Tris, 300 
mM NaCl, 10 mM Imidazol, 0.1% beta-mercaptoethanol (βME), pH 8.0), and lysed using 
sonication. The lysed cells were centrifuged for 45 minutes at 15,000 x g (4°C) to separate the 
cell debris from the proteins in solution. The lysate containing the expressed constructs were 
loaded onto a Ni2+-NTA column by gravity flow. The protein was eluted using an imidazole 
gradient ending with a concentration of 25 mM Tris, 300 mM NaCl, 300 mM Imidazole, and 
0.1% βME, pH 8.0. For the mutagenic Msps TOG3 construct, the His-tag was cleaved using 
Bovine α –Thrombin; whereas, for the Msps TOG1, ch-TOG and Msps TOG5 F1204E 
constructs, the His-tag was cleaved using PreScission Protease. To increase stabilization for CD 
experiments, the His-tag was not cleaved for wild type Msps TOG5 nor for the other mutagenic 
Msps TOG5 constructs. The thrombin was removed using a 0.5 mL benzamidine column. For all 
constructs, excluding those retaining a His-tag, the protein was passed over the Ni2+-NTA 
column a second time to remove any uncleaved His-tagged protein. The protein was 
concentrated and exchanged into storage buffer (10 mM Hepes, 150 mM NaCl, and 0.1% βME, 
pH 7.0). The protein was further concentrated and stored at -80 °C until use. For Msps TOG1, 
ch-TOG TOG3 and TOG5, the protein was concentrated to 15 mg/mL. Msps TOG3 W606E 
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and TOG5 F1204E constructs were concentrated to 8 mg/mL and 13 mg/mL respectively. The 
wild type and mutagenic Msps TOG5 constructs were concentrated to approximately 10 mg/mL. 
C. Crystallization 
Hampton crystal screens were set up for ch-TOG TOGs3 and 5 and MspsTOG3W606E 
and MspsTOG5F1204E using 2 µL of the concentrated protein and 2 µL of a 500 µL well 
solution. To optimize crystals of ch-TOG TOG3 and ch-TOG TOG5, streak-seeding and micro-
seeding methods were utilized. First, Msps TOG3 and TOG5 crystals were harvested. The 
crystals were then extracted and diluted into a larger volume of stabilizing solution to be used as 
seed stock in order to facilitate crystallization of the human homologs. For the streak-seeding 
method, a clean cat whisker was dipped into the seed stock and ran through the experimental 
drops containing ch-TOG TOG3 or ch-TOG TOG5. As for the micro-seeding protocol, 
approximately 1 µL of the seed stock was transferred to a drop containing 1 µL of the 
concentrated protein and 2 µL of a stabilizing solution. Both methods were implemented using 
Msps TOG3 and TOG5 crystals derived from a variety of stabilizing solutions in order to 
enhance crystallization.  
 
Results:  
A. Protein Purification 
 Cloning and purification of the following constructs was successful: Msps TOG1 and 
TOG5, ch-TOG TOG3 and TOG5; and mutagenic constructs Msps TOG3 W606E, TOG5 
R1157 E, E1161R, and F1204E. All of the purified constructs were soluble; however, the 
mutagenic constructs were less soluble than their wild type counterparts due to the expected 
destabilization introduced by the point mutations. Since these constructs have been adequately 
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expressed, purified, and concentrated, they can now be used for further functional analysis and 
characterization experiments to provide a more complete picture of the XMAP215-mediated MT 










B. Structural Analysis 
 Despite efforts to facilitate 
crystallization using micro and streak 
seeding methods, no crystals were 
observed for either TOG domain from ch-
TOG. Upon analyzing the crystallized 
structure of Msps TOG5, it appears that the 
C-terminal tail is slightly unorganized. The 
presence of this disorder suggests that the 
ch-TOG homolog is destabilized, which 
may explain the lack of crystallization.  
Msps TOG3  
W606àE 
Sup. 
Msps TOG3  
W606àE 
Pellet 















Figure 9. SDS-polyacrylamide coomassie stained gel 
showing the solubility of Msps TOG3 (aa. 582-825) 
W606àE and Msps TOG5 (aa. 1141-1411) F1204àE. 
Expected MW for  Msps TOG3 is ~27 kD and that for Msps 
TOG5 is ~31 kD. The rectangle highlights the lack of 
solubility of both mutagenic constructs and the presence of 
the proteins mainly in the pellet.  
Figure 8. SDS-polyacrylamide coomassie stained gel depicting the proteins that were 
successfully cloned and purified. Expected MW for Msps TOG1 = ~24 kD, ch-TOG TOG3 = 
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For the mutagenic Msps TOG domains, the low concentrations of the proteins, along with 
the lack of potential crystallization observed prompted solubility tests to be performed. Both 
Msps TOG3 (W606E) and TOG5 (F1204E) were expressed in larger quantities for 
solubility trials. For both proteins, more than 95% was expressed in the pellet (Fig. 10). Thus, 
these tests support the hypothesis that the introduced mutations destabilize the protein, making it 
insoluble in solution.      
 
Discussion:  
The purification and crystallization of ch-TOG TOG3 (aa 593-828) and TOG5 (aa 1155-
1425) proved to be unsuccessful, perhaps due to the lack of stabilization of the constructs. 
Currently, I am in the process of crystallizing a new TOG5 construct (aa 1155-1422). I 
hypothesize this construct to be more stable than the latter, as some of the residues of the C-
terminal tail are not included within the sequence. Since there is no information to date regarding 
the structures of ch-TOG TOG3 and TOG5, the crystallization of these proteins will provide 
novel information about the structure and will lead to a better understanding of its importance in 
MT dynamics. Furthermore, the crystallization of ch-TOG TOG3 and TOG5 will also confirm 
whether the design of the TOG domains is conserved across domains and various species. In 
addition, I am also working on crystallizing Msps TOG1 to complete the Msps TOG array.   
The attempt to crystallize the mutagenic Msps TOG3 and TOG5 constructs (aa 582-825) 
and (aa 1141-1411) was ineffective due to the insolubility of the proteins. However, I will 
perform subsequent experiments to identify how these mutations effect MT polymerization, 
which will provide further insight into the functionality of these domains and how they facilitate 
MT processes for XMAP215 family proteins.  
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Lastly, I am currently investigating the significance of the extra HR observed in ZYG-9 
TOG3 and Msps TOG5. Three distinct mutations were introduced in Msps TOG5 in order to 
disrupt the interactions between the seventh HR and HRs A-C. Circular dichroism experiments 
will be performed to study how these mutations affect the secondary structure and stability of the 
TOG domain. Ultimately, the combination of these experiments will increase our understanding 
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